FDA Drug · D-1254-2020

Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-018-01

Class I · Terminated

Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.

Affected lots / codes — check yours against thisLot #s: G190609, G190610, G190611, Exp Jun 2022: L191027, L191028, Exp Nov 2022: K190953, K190952, Exp Oct 2022

Recalling firm: Avet Pharmaceuticals, Inc., East Brunswick, NJ
Classification: Class I (most serious — risk of serious harm)
Status: Terminated
Quantity: 17,524 bottles
Distribution: Distributed Nationwide in the US
Recall initiated: March 23, 2020
Classified: April 27, 2020
Terminated: August 23, 2022
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1254-2020%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →